Report for: Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Title	Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
Published in	New Microbes and New Infections, September 2021
DOI	10.1016/j.nmni.2021.100924
Pubmed ID	34466270
Authors	A.D. Santin, D.E. Scheim, P.A. McCullough, M. Yagisawa, T.J. Borody

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 33,766 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	6196	18%
France	1061	3%
United Kingdom	946	3%
Canada	927	3%
Australia	410	1%
Japan	377	1%
Netherlands	298	<1%
Brazil	270	<1%
Italy	178	<1%
Other	2670	8%
Unknown	20433	61%

Demographic breakdown

Type	Count	As %
Members of the public	32531	96%
Practitioners (doctors, other healthcare professionals)	519	2%
Scientists	425	1%
Science communicators (journalists, bloggers, editors)	209	<1%
Unknown	82	<1%

Mendeley readers

The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Unknown	178	100%

Demographic breakdown

Readers by professional status	Count	As %
Researcher	19	11%
Other	18	10%
Student > Bachelor	9	5%
Student > Ph. D. Student	8	4%
Student > Master	8	4%
Other	23	13%
Unknown	93	52%

Readers by discipline	Count	As %
Medicine and Dentistry	22	12%
Biochemistry, Genetics and Molecular Biology	7	4%
Agricultural and Biological Sciences	7	4%
Chemistry	6	3%
Nursing and Health Professions	4	2%
Other	29	16%
Unknown	103	58%

Attention Score in Context

This research output has an Altmetric Attention Score of 16930. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2023.

All research outputs

#50

of 23,412,873 outputs

Outputs from New Microbes and New Infections

of 708 outputs

Outputs of similar age

of 429,923 outputs

Outputs of similar age from New Microbes and New Infections

of 18 outputs

Altmetric has tracked 23,412,873 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 708 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.6. This one has done particularly well, scoring higher than 99% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.

We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context